In this week's video, Dr. Brian GM Durie  suggests ways to manage side effects if you are on a triplet combination.

Make dose adjustments before stopping the combination of Rev, dara, and dex; or use pomalidoide instead of Revlimid.

Have a question? Submit it to

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at

Previous Post
Further FDA clinical trial holds may signal the end for checkpoint inhibitors in myeloma
Next Post
Can New Gene-Editing Tools Provide the Roadmap to A Cure for Myeloma?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.